Covid19_manual_annotation  

PubMed:32798471 JSONTXT 23 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue ForCovid19 all_replicate correct/standard/original word details tao:has_database_id
4 17-25 Disease denotes COVID-19 t MESH:C000657245
5 34-43 Die denotes mortality MESH:D009026
6 47-53 Species denotes people Tax:9606
T2 59-65 Disease denotes type 1 comorbidity MESH:D003922
7 70-85 Disease denotes type 2 diabetes comorbidity MESH:D003924
T3 77-85 Disease denotes diabetes comorbidity MESH:D003922
T50 89-96 Area denotes England
T133 143-151 Disease denotes Diabetes increases|comorbidity MESH:D003920
T143 177-186 Increase denotes increased
85 187-195 Disease denotes COVID-19 t MESH:C000657245
86 204-213 Die denotes mortality MESH:D009026
T53 278-292 Disease denotes hyperglycaemia comorbidity MESH:D006943
T52 297-304 Disease denotes obesity comorbidity MESH:D009765
88 310-318 Disease denotes COVID-19 MESH:C000657245
89 327-336 Die denotes mortality MESH:D009026
90 343-349 Species denotes people Tax:9606
91 355-363 Disease denotes diabetes comorbidity MESH:D003920
92 426-434 Disease denotes COVID-19 MESH:C000657245
93 443-452 Die denotes mortality MESH:D009026
94 456-462 Species denotes people Tax:9606
T6 468-474 Disease denotes type 1 comorbidity MESH:D003922
95 479-494 Disease denotes type 2 diabetes comorbidity MESH:D003924
T7 486-494 Disease denotes diabetes comorbidity MESH:D003922
96 547-553 Species denotes people Tax:9606
97 569-577 Disease denotes diabetes comorbidity MESH:D003920
T54 625-632 Area denotes England
98 662-668 Species denotes people Tax:9606
T9 674-680 Disease denotes type 1 comorbidity MESH:D003922
99 685-700 Disease denotes type 2 diabetes comorbidity MESH:D003924
T11 692-700 Disease denotes diabetes comorbidity MESH:D003922
101 756-765 Die denotes mortality MESH:D009026
102 891-897 Die denotes deaths MESH:D003643
103 901-907 Species denotes people Tax:9606
T13 913-919 Disease denotes type 1 comorbidity MESH:D003922
104 924-939 Disease denotes type 2 diabetes comorbidity MESH:D003924
T15 931-939 Disease denotes diabetes comorbidity MESH:D003922
T141 951-965 Period denotes first 19 weeks
T163 969-973 Year denotes 2020
105 1035-1041 Die denotes deaths MESH:D003643
T105 1165-1190 Condition denotes socioeconomic deprivation
106 1199-1215 Disease denotes renal impairment history MESH:D007674
T109 1222-1258 Index denotes estimated glomerular filtration rate
T110 1260-1264 Index denotes eGFR
T107 1268-1271 Index denotes BMI abbreviation MESH:D015992
T108 1273-1288 Condition denotes tobacco smoking
T55 1301-1329 Disease denotes cardiovascular comorbidities comorbidity
108 1335-1343 Disease denotes COVID-19 MESH:C000657245
109 1352-1361 Die denotes mortality MESH:D009026
T144 1374-1426 Index denotes International Classification of Diseases, version 10
T112 1433-1438 Code denotes U07.1 synonym
T113 1442-1447 Code denotes U07.2 synonym
110 1483-1488 Die denotes death MESH:D003643
T142 1490-1515 Period denotes between Feb 16 and May 11
T172 1517-1521 Year denotes 2020
T145 1551-1582 Method denotes Cox proportional hazards models
T153 1594-1600 Period denotes Weekly
111 1601-1606 Die denotes death MESH:D003643
T152 1628-1642 Period denotes first 19 weeks
T158 1646-1650 Year denotes 2020
T165 1651-1659 Increase denotes exceeded
T157 1678-1684 Period denotes 3-year
T156 1685-1691 Period denotes weekly
T164 1692-1700 Average denotes averages
T160 1705-1707 Year denotes 20
T162 1705-1709 Year denotes 2017
T159 1709-1710 Year denotes - 2018 abbreviation
T161 1710-1712 Year denotes 19
T123 1716-1719 Number denotes 672
T56 1721-1726 Percent denotes 50·9%
112 1731-1737 Species denotes people Tax:9606
T31 1743-1758 Disease denotes type 1 diabetes comorbidity MESH:D003922
T125 1763-1769 Number denotes 16 071
T57 1771-1776 Percent denotes 64·3%
114 1781-1787 Species denotes people Tax:9606
T17 1793-1808 Disease denotes type 2 diabetes comorbidity MESH:D003924
T167 1810-1835 Period denotes Between Feb 16 and May 11
T168 1837-1841 Year denotes 2020
T58 1849-1856 Number denotes 264 390 trial criteria
116 1857-1863 Species denotes people Tax:9606
T33 1869-1884 Disease denotes type 1 diabetes comorbidity MESH:D003922
T59 1889-1898 Number denotes 2 874 020 trial criteria
118 1899-1905 Species denotes people Tax:9606
T19 1911-1926 Disease denotes type 2 diabetes comorbidity MESH:D003924
T60 1928-1932 Number denotes 1604 trial criteria
120 1933-1939 Species denotes people Tax:9606
T35 1945-1960 Disease denotes type 1 diabetes comorbidity MESH:D003922
T61 1965-1971 Number denotes 36 291 trial criteria
122 1972-1978 Species denotes people Tax:9606
T21 1984-1999 Disease denotes type 2 diabetes comorbidity MESH:D003924
T166 2000-2004 Die denotes died MESH:D003643
124 2037-2043 Die denotes deaths MESH:D003643
T129 2045-2048 Number denotes 464 trial criteria
125 2052-2058 Species denotes people Tax:9606
T37 2064-2079 Disease denotes type 1 diabetes comorbidity MESH:D003922
T130 2084-2090 Number denotes 10 525 trial criteria
127 2094-2100 Species denotes people Tax:9606
T23 2106-2121 Disease denotes type 2 diabetes comorbidity MESH:D003924
129 2138-2146 Disease denotes COVID-19 MESH:C000657245
T131 2165-2168 Number denotes 289 trial criteria
T64 2170-2175 Percent denotes 62·3%
T132 2181-2185 Number denotes 5833 trial criteria
T65 2187-2192 Percent denotes 55·4%
130 2221-2227 Species denotes people Tax:9606
T170 2235-2242 Condition denotes history
131 2246-2268 Disease denotes cardiovascular disease history MESH:D002318
132 2277-2293 Disease denotes renal impairment history MESH:D007674
T111 2295-2299 Index denotes eGFR trial criteria
T114 2300-2322 Value denotes <60 mL/min per 1·73 m2 trial criteria
T66 2325-2333 Sex denotes Male sex
T67 2335-2344 Age denotes older age
133 2346-2362 Disease denotes renal impairment MESH:D007674
T68 2364-2383 Species denotes non-white ethnicity Tax:9606
T69 2385-2410 Condition denotes socioeconomic deprivation
T115 2416-2424 Condition denotes previous
134 2425-2431 Disease denotes stroke history MESH:D020521
135 2436-2449 Disease denotes heart failure history MESH:D006333
T169 2471-2480 Increase denotes increased
136 2481-2489 Disease denotes COVID-19 MESH:C000657245
137 2498-2507 Die denotes mortality MESH:D009026
T39 2516-2522 Disease denotes type 1 comorbidity MESH:D003922
138 2527-2542 Disease denotes type 2 diabetes comorbidity MESH:D003924
T41 2534-2542 Disease denotes diabetes comorbidity MESH:D003922
139 2558-2564 Species denotes people Tax:9606
T70 2573-2578 Index denotes HbA1c trial criteria
T71 2582-2596 Value denotes 48-53 mmol/mol trial criteria
T171 2598-2606 Percent denotes 6·5-7·0%
140 2609-2615 Species denotes people Tax:9606
T72 2624-2629 Index denotes HbA1c trial criteria
T73 2633-2644 Value denotes 86 mmol/mol trial criteria
T150 2646-2651 Percent denotes 10·0%
T149 2653-2662 Value denotes or higher trial criteria
T151 2667-2676 Increase denotes increased
141 2677-2685 Disease denotes COVID-19 MESH:C000657245
142 2694-2703 Die denotes mortality MESH:D009026
T74 2705-2717 Index denotes hazard ratio
T146 2719-2721 Index denotes HR synonym
T147 2723-2727 Ratio denotes 2·23
T187 2729-2732 Percent denotes 95%
T43 2760-2775 Disease denotes type 1 diabetes comorbidity MESH:D003922
T76 2780-2784 Ratio denotes 1·61
T25 2810-2825 Disease denotes type 2 diabetes comorbidity MESH:D003924
145 2844-2850 Species denotes people Tax:9606
T27 2856-2871 Disease denotes type 2 diabetes comorbidity MESH:D003924
147 2873-2881 Disease denotes COVID-19 MESH:C000657245
148 2890-2899 Die denotes mortality MESH:D009026
T176 2918-2924 Increase denotes higher
T77 2942-2947 Index denotes HbA1c trial criteria
T78 2951-2962 Value denotes 59 mmol/mol trial criteria
T175 2964-2968 Percent denotes 7·6%
T174 2973-2979 Detail denotes higher trial criteria
T79 3002-3007 Index denotes HbA1c trial criteria
T80 3011-3025 Value denotes 48-53 mmol/mol trial criteria
T134 3027-3029 Index denotes HR
T81 3030-3034 Ratio denotes 1·22
T182 3036-3039 Percent denotes 95%
T180 3068-3082 Value denotes 59-74 mmol/mol trial criteria
T183 3084-3092 Percent denotes 7·6-8·9%
T135 3098-3102 Ratio denotes 1·36
T184 3104-3113 Percent denotes 1·24-1·50
T178 3129-3143 Value denotes 75-85 mmol/mol trial criteria
T181 3145-3153 Percent denotes 9·0-9·9%
T185 3161-3172 Relation denotes association
T84 3181-3184 Index denotes BMI abbreviation MESH:D015992
149 3189-3197 Disease denotes COVID-19 MESH:C000657245
150 3206-3215 Die denotes mortality MESH:D009026
T83 3220-3228 Detail denotes U-shaped
T45 3233-3248 Disease denotes type 1 diabetes comorbidity MESH:D003922
T116 3266-3269 Index denotes BMI trial criteria abbreviation MESH:D015992
T119 3273-3288 Value denotes 25·0-29·9 kg/m2 trial criteria
T140 3292-3295 Index denotes BMI trial criteria abbreviation MESH:D015992
T89 3299-3319 Value denotes less than 20·0 kg/m2 trial criteria
T91 3327-3329 Index denotes HR
T86 3333-3337 Ratio denotes 2·45
T186 3339-3342 Percent denotes 95%
T118 3373-3376 Index denotes BMI abbreviation MESH:D015992
T90 3380-3400 Value denotes 40·0 kg/m2 or higher
T92 3408-3410 Index denotes HR
T88 3414-3418 Ratio denotes 2·33
T29 3468-3483 Disease denotes type 2 diabetes comorbidity MESH:D003924
T93 3489-3493 Ratio denotes 2·33
T94 3520-3524 Ratio denotes 1·60
153 3564-3570 Die denotes Deaths MESH:D003643
154 3574-3580 Species denotes people Tax:9606
T47 3586-3592 Disease denotes type 1 comorbidity MESH:D003922
155 3597-3612 Disease denotes type 2 diabetes comorbidity MESH:D003924
T49 3604-3612 Disease denotes diabetes comorbidity MESH:D003922
T188 3613-3617 Increase denotes rose
T189 3618-3625 Condition denotes sharply
T190 3637-3662 Period denotes initial COVID-19 pandemic
T95 3666-3673 Area denotes England
T191 3675-3684 Increase denotes Increased
157 3685-3693 Disease denotes COVID-19 MESH:D000086382
158 3702-3711 Die denotes mortality MESH:D009026
T120 3741-3755 Biological denotes cardiovascular
T98 3760-3790 Disease denotes renal complications of diabete comorbidity MESH:D003928
T121 3766-3790 Disease denotes complications of diabete comorbidity
T96 3822-3839 Therapy denotes glycaemic control
T97 3844-3847 Index denotes BMI abbreviation MESH:D015992
R1 T2 T3 - type 1,diabetes
R128 T89 T86 is_a less than 20·0 kg/m2,2·45
R130 T141 102 in first 19 weeks,deaths
R131 T142 109 in between Feb 16 and May 11,mortality
R132 T2 6 has_a type 1,people
R133 7 6 has_a type 2 diabetes,people
R134 T50 6 in England,people
R136 6 5 is_a people,mortality
R138 85 86 of_a COVID-19,mortality
R140 91 90 has_a diabetes,people
R141 T112 108 of_a U07.1,COVID-19
R142 T113 108 of_a U07.2,COVID-19
R143 T144 T112 of_a "International Classification of Diseases, version 10",U07.1
R144 T144 T113 of_a "International Classification of Diseases, version 10",U07.2
R145 T146 T74 is_a HR,hazard ratio
R146 T147 T74 of_a 2·23,hazard ratio
R147 T76 T74 of_a 1·61,hazard ratio
R148 141 142 of_a COVID-19,mortality
R149 T73 T149 - 86 mmol/mol,or higher
R150 T150 T73 is_a 10·0%,86 mmol/mol
R151 T72 T151 relates HbA1c,increased
R153 T43 T147 of_a type 1 diabetes,2·23
R154 T25 T76 of_a type 2 diabetes,1·61
R156 T31 112 has_a type 1 diabetes,people
R157 T17 114 has_a type 2 diabetes,people
R158 T160 T161 - 20,19
R159 T162 T157 is_a 2017,3-year
R160 T159 T157 is_a -,3-year
R161 T160 T157 is_a 20,3-year
R162 T163 T141 in 2020,first 19 weeks
R164 T153 111 in Weekly,death
R168 T156 T164 in weekly,averages
R169 T164 111 coreference averages,death
R171 T156 T152 coreference weekly,first 19 weeks
R172 111 T165 is_a death,exceeded
R173 T123 T165 of_a 672,exceeded
R174 T125 T165 of_a 16 071,exceeded
R175 T56 T123 is_a 50·9%,672
R176 T57 T125 is_a 64·3%,16 071
R177 112 T123 of_a people,672
R178 T17 114 of_a type 2 diabetes,people
R179 114 T125 of_a people,16 071
R180 T157 T156 in 3-year,weekly
R181 T152 111 in first 19 weeks,death
R182 T158 T152 in 2020,first 19 weeks
R183 T164 T165 against averages,exceeded
R184 T33 116 has_a type 1 diabetes,people
R185 T19 118 has_a type 2 diabetes,people
R186 T60 T166 is_a 1604,died
R187 T61 T166 is_a 36 291,died
R188 116 T58 of_a people,264 390
R189 118 T59 of_a people,2 874 020
R190 T58 T60 in 264 390,1604
R191 T59 T61 in 2 874 020,36 291
R192 T168 T167 in 2020,Between Feb 16 and May 11
R193 T167 T166 in Between Feb 16 and May 11,died
R194 T60 T129 in 1604,464
R195 T61 T130 in 36 291,10 525
R196 T129 124 has_a 464,deaths
R197 T130 124 has_a 10 525,deaths
R198 129 124 cause_of COVID-19,deaths
R199 T129 T131 in 464,289
R2 T6 T7 - type 1,diabetes
R200 T130 T132 in 10 525,5833
R201 T64 T131 is_a 62·3%,289
R202 T65 T132 is_a 55·4%,5833
R203 125 T129 of_a people,464
R204 127 T130 of_a people,10 525
R205 T37 125 has_a type 1 diabetes,people
R206 T23 127 has_a type 2 diabetes,people
R207 131 130 has_a cardiovascular disease,people
R208 132 130 has_a renal impairment,people
R209 130 T131 of_a people,289
R210 130 T132 of_a people,5833
R211 T114 T111 of_a <60 mL/min per 1·73 m2,eGFR
R212 132 T111 has_status renal impairment,eGFR
R213 T39 137 of_a type 1,mortality
R214 138 137 of_a type 2 diabetes,mortality
R215 137 T169 cause_of mortality,increased
R216 136 137 of_a COVID-19,mortality
R217 T66 T169 relates Male sex,increased
R218 T67 T169 relates older age,increased
R219 133 T169 relates renal impairment,increased
R220 T68 T169 relates non-white ethnicity,increased
R221 T69 T169 relates socioeconomic deprivation,increased
R222 134 T169 relates stroke,increased
R223 135 T169 relates heart failure,increased
R224 131 T170 has_status cardiovascular disease,history
R225 132 T170 has_status renal impairment,history
R226 134 T115 has_status stroke,previous
R227 135 T115 has_status heart failure,previous
R229 T172 T142 in 2020,between Feb 16 and May 11
R230 T110 T109 abbreviation eGFR,estimated glomerular filtration rate
R231 T72 140 of_a HbA1c,people
R232 T70 139 of_a HbA1c,people
R233 T70 T151 against HbA1c,increased
R234 T81 T134 of_a 1·22,HR
R235 T135 T134 of_a 1·36,HR
R236 T175 T78 is_a 7·6%,59 mmol/mol
R237 T78 T174 - 59 mmol/mol,higher
R238 T27 145 has_a type 2 diabetes,people
R239 147 148 of_a COVID-19,mortality
R241 T27 148 of_a type 2 diabetes,mortality
R242 T77 T176 relates HbA1c,higher
R243 4 5 of_a COVID-19,mortality
R244 T133 T143 relates Diabetes,increased
R245 86 T143 cause_of mortality,increased
R246 88 89 of_a COVID-19,mortality
R247 92 93 of_a COVID-19,mortality
R248 97 96 has_a diabetes,people
R249 T54 96 in England,people
R250 108 109 of_a COVID-19,mortality
R251 142 T151 cause_of mortality,increased
R252 148 T176 cause_of mortality,higher
R253 T79 T176 against HbA1c,higher
R254 T181 T178 is_a 9·0-9·9%,75-85 mmol/mol
R255 T182 T81 is_a 95%,1·22
R256 T183 T180 is_a 7·6-8·9%,59-74 mmol/mol
R257 T184 T135 is_a 1·24-1·50,1·36
R260 149 150 of_a COVID-19,mortality
R261 T83 T185 is_a U-shaped,association
R262 T84 T185 of_a BMI,association
R263 150 T185 of_a mortality,association
R264 T71 T70 of_a 48-53 mmol/mol,HbA1c
R265 T171 T71 is_a 6·5-7·0%,48-53 mmol/mol
R266 T78 T77 of_a 59 mmol/mol,HbA1c
R267 T180 T77 coreference 59-74 mmol/mol,HbA1c
R268 T73 T72 of_a 86 mmol/mol,HbA1c
R269 T187 T147 is_a 95%,2·23
R270 T80 T79 of_a 48-53 mmol/mol,HbA1c
R271 T178 T77 coreference 75-85 mmol/mol,HbA1c
R272 T180 T81 of_a 59-74 mmol/mol,1·22
R273 T178 T135 of_a 75-85 mmol/mol,1·36
R274 T186 T86 is_a 95%,2·45
R275 T86 T91 of_a 2·45,HR
R276 T88 T92 of_a 2·33,HR
R277 T119 T116 of_a 25·0-29·9 kg/m2,BMI
R278 T89 T140 of_a less than 20·0 kg/m2,BMI
R279 T74 T151 cause_of hazard ratio,increased
R280 T134 T176 cause_of HR,higher
R281 T140 T91 relates BMI,HR
R282 T116 T91 against BMI,HR
R283 T45 T86 of_a type 1 diabetes,2·45
R284 T90 T118 of_a 40·0 kg/m2 or higher,BMI
R285 T118 T92 relates BMI,HR
R286 T116 T92 against BMI,HR
R287 T29 T93 of_a type 2 diabetes,2·33
R288 T93 T91 of_a 2·33,HR
R289 T94 T92 of_a 1·60,HR
R290 T29 T94 of_a type 2 diabetes,1·60
R291 T47 154 has_a type 1,people
R292 155 154 has_a type 2 diabetes,people
R293 153 154 of_a Deaths,people
R294 153 T188 is_a Deaths,rose
R295 T95 153 in England,Deaths
R296 T189 T188 of_a sharply,rose
R298 T190 153 in initial COVID-19 pandemic,Deaths
R299 157 158 of_a COVID-19,mortality
R3 T9 T11 - type 1,diabetes
R300 158 T191 relates mortality,Increased
R301 T120 T191 cause_of cardiovascular,Increased
R302 T98 T191 cause_of renal complications of diabete,Increased
R303 T96 T191 cause_of glycaemic control,Increased
R304 T97 T191 cause_of BMI,Increased
R4 T13 T15 - type 1,diabetes
R5 T39 T41 - type 1,diabetes
R56 T77 148 increases HbA1c,mortality
R6 T47 T49 - type 1,diabetes
R87 T120 T121 - cardiovascular,complications of diabete